CCL2 and infectious otitis media: Specific targeting of CCL2 activity through intraperitoneal injection of chemokine receptor 2 and chemokine receptor 4 inhibitors during ALF in AOM‐or TAA‐treated mice was found to reduce microglia activation and improve neurological function [72, 73].